Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-089868
Filing Date
2022-03-30
Accepted
2022-03-30 16:31:11
Documents
6
Effectiveness Date
2022-03-30

Document Format Files

Seq Description Document Type Size
1 S-8 d268810ds8.htm S-8 42772
2 EX-5.1 d268810dex51.htm EX-5.1 5302
3 EX-23.1 d268810dex231.htm EX-23.1 1453
4 EX-FILING FEES d268810dexfilingfees.htm EX-FILING FEES 20588
5 GRAPHIC g268810dsp004.jpg GRAPHIC 10608
6 GRAPHIC g268810dsp005.jpg GRAPHIC 1502
  Complete submission text file 0001193125-22-089868.txt   88234
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263983 | Film No.: 22786920
SIC: 2834 Pharmaceutical Preparations